コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ane-bound proteins (NADH dehydrogenase I and succinate dehydrogenase).
2 alpha-ketoglutarate dehydrogenase (KGDH) and succinate dehydrogenase.
3 ndrial proteins such as lipoate synthase and succinate dehydrogenase.
4 emical staining for cytochrome c oxidase and succinate dehydrogenase.
5 n, affects respiratory electron flow through succinate dehydrogenase.
6 eing a consequence of the effects of 3NPA on succinate dehydrogenase.
7 ctase-phospholipid vesicles replenished with succinate dehydrogenase.
8 ropionic acid (3-NP), a suicide inhibitor of succinate dehydrogenase.
9 reconstitutive activity of the mitochondrial succinate dehydrogenase.
10 ronments are not affected by the presence of succinate dehydrogenase.
11 es in the iron-sulfur enzymes, aconitase and succinate dehydrogenase.
12 dehydrogenase I, NADH dehydrogenase II, and succinate dehydrogenase.
13 analysis, pyruvate dehydrogenase complex and succinate dehydrogenase.
14 ropionate, a known irreversible inhibitor of succinate dehydrogenase.
15 h1, a subunit of the heterotetrameric enzyme succinate dehydrogenase.
16 y sensitive to the irreversible inhibitor of succinate dehydrogenase 3-nitropropionic acid (3-NP).
18 er normoxic conditions through regulation of succinate dehydrogenase A (SDHA) and fumarate hydratase
19 ome c oxidase subunits 1 and 2) and nuclear (succinate dehydrogenase A) DNA-encoded respiratory chain
22 ining proteins are down-regulated, including succinate dehydrogenase, aconitase, cytochromes, and bio
24 analyses of the catalysis and inhibition of succinate dehydrogenase activities in samples with both
26 f reactive oxygen species (ROS); 2) decrease succinate dehydrogenase activity (complex II of the elec
27 oxidase activity (COX-), hyperreactivity for succinate dehydrogenase activity (SDH++; also known as r
28 e in capillary density and a 23% increase in succinate dehydrogenase activity after 3 months of condi
29 ex II's electron transport function from its succinate dehydrogenase activity also suggested a mechan
31 y 4HNE is shown to involve the disruption of succinate dehydrogenase activity and subsequent activati
33 ere was, however, a significant reduction in succinate dehydrogenase activity associated with OAT act
34 :cat(+) strain exhibited wild-type levels of succinate dehydrogenase activity both in vivo and in vit
37 Peak VO2 was strongly related to integrated succinate dehydrogenase activity in patients (r = 0.896,
38 respiratory complex protein expression, and succinate dehydrogenase activity in skeletal muscles.
39 arate was provided to alleviate the need for succinate dehydrogenase activity in the tricarboxylic ac
40 A::cat(+) strain was completely deficient in succinate dehydrogenase activity in vitro and was unable
45 sectional area was smaller, and single-fiber succinate dehydrogenase activity, a mitochondrial oxidat
46 rmogenesis, indicated by increases in muscle succinate dehydrogenase activity, SLN expression, mitoch
47 29SVEMS mice have a significant reduction of succinate dehydrogenase activity, succinate oxygen consu
48 r wild type grown under conditions requiring succinate dehydrogenase activity, suggesting that the su
49 and a reduction of cytochrome c oxidase and succinate dehydrogenase activity, when compared with non
54 containing 5 coimmunoprecipitating proteins (succinate dehydrogenase, adenine nucleotide translocator
55 l cytochemistry for cytochrome c oxidase and succinate dehydrogenase allowed the detection of cytochr
56 onsumption of soy was associated with higher succinate dehydrogenase alpha levels and lower levels of
58 presence of oxidized cytochrome c, purified succinate dehydrogenase also catalyzed oxidation of succ
60 ition of the tricarboxylic acid cycle enzyme succinate dehydrogenase, also known as complex II of the
61 Malonic acid methyl ester, an inhibitor of succinate dehydrogenase, also specifically increased glu
62 and for the function, but not stability, of succinate dehydrogenase, an important component of the e
63 into a reconstitutively active, two-subunit succinate dehydrogenase and a two-subunit membrane ancho
64 further confirmed by observing decreases in succinate dehydrogenase and aconitase activities, whose
66 hern Sweden, with associated deficiencies of succinate dehydrogenase and aconitase in skeletal muscle
68 hondrial (mt) DNA and polypeptide abundance, succinate dehydrogenase and cytochrome oxidase histochem
69 s that TRX may deactivate both mitochondrial succinate dehydrogenase and fumarase and activate the cy
70 ccinyl-CoA ligase mutants, elevated again in succinate dehydrogenase and fumarase mutants, and dimini
72 which can accumulate to millimolar levels in succinate dehydrogenase and fumarate hydratase-mutant tu
73 rity to genes coding for the FeS subunits of succinate dehydrogenase and fumarate reductase, were del
74 ty of two mitochondrial iron-sulfur enzymes, succinate dehydrogenase and mitochondrial aconitase, as
77 arkers of mitochondria (citrate synthase and succinate dehydrogenase) and glucose uptake capacity (GL
78 mRNAs for sodB (superoxide dismutase), sdh (succinate dehydrogenase), and a gene encoding a bacterio
79 sdh3 and sdh4 (encoding subunits 3 and 4 of succinate dehydrogenase), and we also show that these ge
80 d the activities of NADH dehydrogenase (ND), succinate dehydrogenase, and cytochrome c oxidase (COX)
81 ey electron transfer proteins (flavoprotein, succinate dehydrogenase, and cytochrome c) and the synth
83 y succinate in the presence of mitochondrial succinate dehydrogenase, and the rate of cytochrome b556
84 es of mitochondrial Fe-S enzymes (aconitase, succinate dehydrogenase, and ubiquinol-cytochrome c oxid
86 mRNA levels for the sdhCDAB operon, encoding succinate dehydrogenase, as well as five other genes pre
87 and determines total protein content, and a succinate dehydrogenase assay that uses dichloroindophen
88 and the respiratory chain Complex II subunit succinate dehydrogenase B (SDHB) in mitochondria of tumo
89 th von Hippel Lindau syndrome (VHL; n = 19), succinate dehydrogenase B-D mutation (n = 21), neurofibr
91 electron transport chain Complex II subunit succinate dehydrogenase-B, maintaining cellular respirat
92 y iron-sulfur enzymes, such as aconitase and succinate dehydrogenase, but also alters the regulation
93 ogenase, fumarase, malate dehydrogenase, and succinate dehydrogenase, but not KDH, are present, raisi
94 lie proximal to the divergently transcribed succinate dehydrogenase C gene, but Sdhc expression was
95 ductive pathway in the opposite direction of succinate dehydrogenase, can replace it during infection
97 onic acid (3-NP) and malonate, inhibitors of succinate dehydrogenase, compared with control cell line
100 2.4%; P < .001), COX4 (26.6%; P < .001), and succinate dehydrogenase complex subunit A (65.8%; P = .0
101 ein levels (P = 0.0006 and P = 0.005) of the succinate dehydrogenase complex subunit A and subunit B
103 t results in the localization of sympathetic succinate dehydrogenase complex, subunit B, mutation-rel
104 ve metabolism in mice with disruption of the succinate dehydrogenase complex, subunit C gene (Sdhc).
107 three sites, NADH dehydrogenase (complex I), succinate dehydrogenase (complex II), and cytochrome c o
108 n enzymes NADH-dehydrogenase (complex I) and succinate dehydrogenase (complex II), inactivation of th
110 l0823 open reading frames encode subunits of succinate dehydrogenase complexes that are active in the
112 s, the differential diagnosis should include succinate dehydrogenase deficiency, in particular if MRS
115 rial marker enzymes cytochrome C oxidase and succinate dehydrogenase, demonstrate abnormal accumulati
116 the largest subcomplex (IIa) represents the succinate dehydrogenase domain composed of SDH1 and SDH2
117 umulated succinate is rapidly re-oxidized by succinate dehydrogenase, driving extensive ROS generatio
119 e identified one of the Complex II subunits, succinate dehydrogenase flavoprotein (SdhA) subunit, as
120 fumarase (fum-1), glyoxylate shunt (gei-7), succinate dehydrogenase flavoprotein (sdha-2), or solubl
121 d in metabolism (ATP synthase alpha-subunit, succinate dehydrogenase flavoprotein [SDH Fp] subunit, a
122 opionic acid, an irreversible inactivator of succinate dehydrogenase, forms a covalent adduct with th
124 e patient series that germline variations in succinate dehydrogenase genes (SDHx) occur in 8% (49/608
125 of the virulence-associated Rv0249c-Rv0247c succinate dehydrogenase genes demonstrated that CRP dire
129 tochondrial genes for fumarate hydratase and succinate dehydrogenase have been linked to uterine leio
130 Abundance of the 17-kd subunit of complex I, succinate dehydrogenase histochemical activity, and cris
131 ETS-abnormal, cytochrome c oxidase-negative/succinate dehydrogenase-hyperreactive (COX-/SDH++) fiber
132 These data indicate that Frd is the only succinate dehydrogenase in C. jejuni and that the protei
133 ty possibly resulting from inhibition of the succinate dehydrogenase in heart mitochondria, contribut
134 nfection by running in the same direction as succinate dehydrogenase in order to run a full TCA cycle
135 PQI toxicity in isolated liver mitochondria (succinate dehydrogenase inactivation, SDH) from these ra
136 ction and the most significant member of the succinate dehydrogenase inhibitor group of fungicides.
138 ly that flavinylation of the Sdh1 subunit of succinate dehydrogenase is dependent on a set of two spa
139 esults demonstrate that in vitro activity of succinate dehydrogenase is modulated by the protonmotive
141 complete tricarboxylic acid (TCA) cycle and succinate dehydrogenase is small under heterotrophic con
142 These results suggest that reduced FAD of succinate dehydrogenase is the electron donor for oxygen
144 ivity of Fe-S-containing enzymes (aconitase, succinate dehydrogenase) is decreased, whereas the activ
145 It was previously shown that mutations in succinate dehydrogenase lead to the inactivation PHDs un
148 NA encoding the iron protein (Ip) subunit of succinate dehydrogenase of yeast is its rate of turnover
149 ty between FsrA and the leader region of the succinate dehydrogenase operon is consistent with an RNA
151 eductase activity increases as the amount of succinate dehydrogenase or the SdhC-SdhD fraction added
152 hD fraction is mixed with varying amounts of succinate dehydrogenase or vice versa succinate-ubiquino
154 ontrast, similar cation depletion stimulates succinate dehydrogenase (or glutamate dehydrogenase) in
155 gh potential 3Fe-4S cluster, situated in the succinate dehydrogenase part of the enzyme, and the low
156 teins, YgfY (a DUF339 protein, renamed SdhE; succinate dehydrogenase protein E) and YgfX (a DUF1434 p
158 value of 3.37, obtained by assuming 1 mol of succinate dehydrogenase reacts with 1 mol of SdhC and Sd
160 han unimodal distribution of sizes and lower succinate dehydrogenase (SDH) activities for neurons of
161 d origin of each peak were assessed by using succinate dehydrogenase (SDH) activity as the IM marker
162 and analysis of biochemical traits including succinate dehydrogenase (SDH) activity, ATP content and
164 sed mitochondrial oxidation of succinate via succinate dehydrogenase (SDH) and an elevation of mitoch
166 rs was supplied by the recent discovery that succinate dehydrogenase (SDH) and fumarate hydratase (FH
167 5 interact with the catalytic subunit of the succinate dehydrogenase (SDH) complex, a component of bo
169 mocytomas and paragangliomas associated with succinate dehydrogenase (SDH) deficiency are characteriz
171 tion of myosin heavy chain (MHC) IIB and low succinate dehydrogenase (SDH) expressing myofibers, with
173 ional role for stretch-induced inhibition of succinate dehydrogenase (SDH) in mediating normoxic HIF1
174 ng mutation in the TCA cycle enzyme complex, succinate dehydrogenase (SDH) in paraganglioma (PGL), it
184 activity with cytochrome c oxidase (COX) and succinate dehydrogenase (SDH) staining, retinal layer th
186 imutation of additional genes, including the succinate dehydrogenase (SDH) subunit A, B, C, and D gen
187 ed by immunohistochemical analysis (IHC) for succinate dehydrogenase (SDH) subunit B, sequencing of S
189 anglioma, is caused by germline mutations in succinate dehydrogenase (SDH) subunits B, C, or D, leadi
190 actor-1 (HIF-1), but mutations in Complex II-succinate dehydrogenase (SDH), a tumor suppressor, stabi
192 nts demonstrated that they were defective in succinate dehydrogenase (Sdh), an enzyme of the tricarbo
193 at alpha-ketoglutarate dehydrogenase (KGDH), succinate dehydrogenase (SDH), and aconitase were suscep
194 rs: mutated isocitrate dehydrogenases (IDH), succinate dehydrogenase (SDH), and fumarate hydratase (F
195 ic acid (TCA) cycle, including aconitase and succinate dehydrogenase (SDH), are major targets of FsrA
196 have been identified in the metabolic genes succinate dehydrogenase (SDH), fumarate hydratase (FH) a
197 bstrate methylmalonyl-CoA and which inhibits succinate dehydrogenase (SDH), produced dose-related cel
198 rt that suppression requires inactivation of succinate dehydrogenase (SDH), which greatly reduces the
199 Although there was no difference in percent succinate dehydrogenase (SDH)-positive (type I) and SDH-
202 sophila mutant with a defect in subunit b of succinate dehydrogenase (SDH; mitochondrial complex II).
204 coding subunit B of the mitochondrial enzyme succinate dehydrogenase (SDHB) predispose to malignant p
205 s cycle enzymes, fumarate hydratase (FH) and succinate dehydrogenase (SDHB, -C and -D), act as tumour
209 ady-state levels of the catalytic complex II succinate dehydrogenase subunit A alongside hyperpigment
211 Analysis of the proteins in TCA cycle showed succinate dehydrogenase subunit B (SDHB) was nearly depl
212 and aggressiveness in certain patients with succinate dehydrogenase subunit B(SDHB) mutations sugges
213 ransport chain with a down-regulation of the succinate dehydrogenase subunit B, leading to deregulati
215 r-suppressor gene and germline variations in succinate dehydrogenase subunit D gene (SDHD-G12S, SDHD-
216 tations in SDHD, a mitochondrial complex II (succinate dehydrogenase) subunit gene at chromosome band
219 tural and catalytic properties of beef heart succinate dehydrogenase (succinate-ubiquinone oxidoreduc
220 acid (3-NP), is an irreversible inhibitor of succinate dehydrogenase that induces apoptosis in vitro
221 nitropropionic acid (3-NP) are inhibitors of succinate dehydrogenase that produce energy depletion an
222 itution is obtained when the weight ratio of succinate dehydrogenase to the SdhC-SdhD fraction reache
223 -nitropropionic acid (3-NP), an inhibitor of succinate dehydrogenase, to produce neurodegeneration.
224 twitch markers [myosin heavy chain 7 (MyH7), succinate dehydrogenase, troponin I 1, troponin C1, trop
225 ding the VHL, MET, FLCN, fumarate hydratase, succinate dehydrogenase, TSC1, TSC2, and TFE3 genes, hav
226 = 1), SDHB (n = 2), and SDHD (n = 4) (SDH is succinate dehydrogenase); von Hippel-Lindau (VHL; n = 2)
234 -CoA to succinate, and a DeltasdhCDA mutant (succinate dehydrogenase), which blocks the conversion of
235 ccinate accumulation arises from reversal of succinate dehydrogenase, which in turn is driven by fuma
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。